Sheldon X. Kong, PhD

home / authors / sheldon-x-kong-phd

Articles

Site Logo
December 8th 2021

Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Jinlin Song, PhD Elizabeth Faust, MBA, MPH Karen Yang, BA Yuxian Du, PhD Sheldon X. Kong, PhD Rakesh Singh, PhD
Site Logo
June 1st 2001

Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis

Elliott W. Ehrich, MD James A. Bolognese, Mstat Douglas J. Watson, PhD Sheldon X. Kong, PhD

Site Logo
March 1st 1998

Prevalence and Cost of Hospitalization for Gastrointestinal Complications Related to Peptic Ulcers with Bleeding or Perforation: Comparison of Two National Databases

Sheldon X. Kong, PhD Hind T. Hatoum, PhD Sean Z. Zhao, MD, PhD Naurang M. Argrawal, MD Steve G. Geis, MD, PhD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
AJMC EBO logo | Image credit : AJMC
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo